Loading…

Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo

The serine/threonine kinase RIPK1 is recruited to TNFR1 to mediate proinflammatory signaling and to regulate TNF-induced cell death. A RIPK1 deficiency results in perinatal lethality, impaired NFκB and MAPK signaling, and sensitivity to TNF-induced apoptosis. Chemical inhibitor and in vitro-reconsti...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) 2014-08, Vol.193 (4), p.1539-1543
Main Authors: Polykratis, Apostolos, Hermance, Nicole, Zelic, Matija, Roderick, Justine, Kim, Chun, Van, Trieu-My, Lee, Thomas H, Chan, Francis K M, Pasparakis, Manolis, Kelliher, Michelle A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-962bd451946220134e93616c9e00658e11835c4b9eceb1396fb2f307fc6af623
cites cdi_FETCH-LOGICAL-c440t-962bd451946220134e93616c9e00658e11835c4b9eceb1396fb2f307fc6af623
container_end_page 1543
container_issue 4
container_start_page 1539
container_title The Journal of immunology (1950)
container_volume 193
creator Polykratis, Apostolos
Hermance, Nicole
Zelic, Matija
Roderick, Justine
Kim, Chun
Van, Trieu-My
Lee, Thomas H
Chan, Francis K M
Pasparakis, Manolis
Kelliher, Michelle A
description The serine/threonine kinase RIPK1 is recruited to TNFR1 to mediate proinflammatory signaling and to regulate TNF-induced cell death. A RIPK1 deficiency results in perinatal lethality, impaired NFκB and MAPK signaling, and sensitivity to TNF-induced apoptosis. Chemical inhibitor and in vitro-reconstitution studies suggested that RIPK1 displays distinct kinase activity-dependent and -independent functions. To determine the contribution of RIPK1 kinase to inflammation in vivo, we generated knock-in mice endogenously expressing catalytically inactive RIPK1 D138N. Unlike Ripk1(-/-) mice, which die shortly after birth, Ripk1(D138N/D138N) mice are viable. Cells expressing RIPK1 D138N are resistant to TNF- and polyinosinic-polycytidylic acid-induced necroptosis in vitro, and Ripk1(D138N/D138N) mice are protected from TNF-induced shock in vivo. Moreover, Ripk1(D138N/D138N) mice fail to control vaccinia virus replication in vivo. This study provides genetic evidence that the kinase activity of RIPK1 is not required for survival but is essential for TNF-, TRIF-, and viral-initiated necroptosis.
doi_str_mv 10.4049/jimmunol.1400590
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808622892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808622892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-962bd451946220134e93616c9e00658e11835c4b9eceb1396fb2f307fc6af623</originalsourceid><addsrcrecordid>eNo9kM1LAzEQxYMotlbvniRHL6uTbJJuvEnxo7SoSO_LbnZSUvajbrIF_3tT2nqZGYb3fjweIbcMHgQI_bhxTTO0Xf3ABIDUcEbGTEpIlAJ1TsYAnCdsqqYjcuX9BgAUcHFJRlwCkxlnY2JnQwiuXVOs1vhEv-dfC0YXri080jhNcDukjTNIix7pzhVlHc-2otu-C2gCVtT2XUNXH6-Ja6vBxEeLpu-2ofPOR0Y07bprcmGL2uPNcU_I6vVlNXtPlp9v89nzMjFCQEi04mUlJNNCcQ4sFahTxZTRGKPLDBnLUmlEqdFgyVKtbMltClNrVGEVTyfk_oCN6X4G9CFvnDdY10WL3eBzlkEWyZneS-EgjVm979Hm2941Rf-bM8j35eancvNjudFyd6QPZYPVv-HUZvoH4Z52QQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808622892</pqid></control><display><type>article</type><title>Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo</title><source>EZB Electronic Journals Library</source><creator>Polykratis, Apostolos ; Hermance, Nicole ; Zelic, Matija ; Roderick, Justine ; Kim, Chun ; Van, Trieu-My ; Lee, Thomas H ; Chan, Francis K M ; Pasparakis, Manolis ; Kelliher, Michelle A</creator><creatorcontrib>Polykratis, Apostolos ; Hermance, Nicole ; Zelic, Matija ; Roderick, Justine ; Kim, Chun ; Van, Trieu-My ; Lee, Thomas H ; Chan, Francis K M ; Pasparakis, Manolis ; Kelliher, Michelle A</creatorcontrib><description>The serine/threonine kinase RIPK1 is recruited to TNFR1 to mediate proinflammatory signaling and to regulate TNF-induced cell death. A RIPK1 deficiency results in perinatal lethality, impaired NFκB and MAPK signaling, and sensitivity to TNF-induced apoptosis. Chemical inhibitor and in vitro-reconstitution studies suggested that RIPK1 displays distinct kinase activity-dependent and -independent functions. To determine the contribution of RIPK1 kinase to inflammation in vivo, we generated knock-in mice endogenously expressing catalytically inactive RIPK1 D138N. Unlike Ripk1(-/-) mice, which die shortly after birth, Ripk1(D138N/D138N) mice are viable. Cells expressing RIPK1 D138N are resistant to TNF- and polyinosinic-polycytidylic acid-induced necroptosis in vitro, and Ripk1(D138N/D138N) mice are protected from TNF-induced shock in vivo. Moreover, Ripk1(D138N/D138N) mice fail to control vaccinia virus replication in vivo. This study provides genetic evidence that the kinase activity of RIPK1 is not required for survival but is essential for TNF-, TRIF-, and viral-initiated necroptosis.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.1400590</identifier><identifier>PMID: 25015821</identifier><language>eng</language><publisher>United States</publisher><subject>Adaptor Proteins, Vesicular Transport - immunology ; Animals ; Apoptosis - drug effects ; Apoptosis - immunology ; Cells, Cultured ; Gene Knock-In Techniques ; Hypothermia - chemically induced ; Hypothermia - mortality ; Inflammation - genetics ; Inflammation - immunology ; Macrophages - immunology ; MAP Kinase Signaling System - immunology ; Mice ; Mice, Inbred C57BL ; Necrosis - chemically induced ; Necrosis - immunology ; NF-kappa B - immunology ; Poly I-C - pharmacology ; Receptor-Interacting Protein Serine-Threonine Kinases - genetics ; Receptor-Interacting Protein Serine-Threonine Kinases - immunology ; Receptors, Tumor Necrosis Factor, Type I - immunology ; Tumor Necrosis Factor-alpha - immunology ; Tumor Necrosis Factor-alpha - pharmacology ; Vaccinia - immunology ; Vaccinia virus ; Vaccinia virus - growth &amp; development ; Vaccinia virus - immunology ; Virus Replication - immunology</subject><ispartof>The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1539-1543</ispartof><rights>Copyright © 2014 by The American Association of Immunologists, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-962bd451946220134e93616c9e00658e11835c4b9eceb1396fb2f307fc6af623</citedby><cites>FETCH-LOGICAL-c440t-962bd451946220134e93616c9e00658e11835c4b9eceb1396fb2f307fc6af623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25015821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Polykratis, Apostolos</creatorcontrib><creatorcontrib>Hermance, Nicole</creatorcontrib><creatorcontrib>Zelic, Matija</creatorcontrib><creatorcontrib>Roderick, Justine</creatorcontrib><creatorcontrib>Kim, Chun</creatorcontrib><creatorcontrib>Van, Trieu-My</creatorcontrib><creatorcontrib>Lee, Thomas H</creatorcontrib><creatorcontrib>Chan, Francis K M</creatorcontrib><creatorcontrib>Pasparakis, Manolis</creatorcontrib><creatorcontrib>Kelliher, Michelle A</creatorcontrib><title>Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>The serine/threonine kinase RIPK1 is recruited to TNFR1 to mediate proinflammatory signaling and to regulate TNF-induced cell death. A RIPK1 deficiency results in perinatal lethality, impaired NFκB and MAPK signaling, and sensitivity to TNF-induced apoptosis. Chemical inhibitor and in vitro-reconstitution studies suggested that RIPK1 displays distinct kinase activity-dependent and -independent functions. To determine the contribution of RIPK1 kinase to inflammation in vivo, we generated knock-in mice endogenously expressing catalytically inactive RIPK1 D138N. Unlike Ripk1(-/-) mice, which die shortly after birth, Ripk1(D138N/D138N) mice are viable. Cells expressing RIPK1 D138N are resistant to TNF- and polyinosinic-polycytidylic acid-induced necroptosis in vitro, and Ripk1(D138N/D138N) mice are protected from TNF-induced shock in vivo. Moreover, Ripk1(D138N/D138N) mice fail to control vaccinia virus replication in vivo. This study provides genetic evidence that the kinase activity of RIPK1 is not required for survival but is essential for TNF-, TRIF-, and viral-initiated necroptosis.</description><subject>Adaptor Proteins, Vesicular Transport - immunology</subject><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - immunology</subject><subject>Cells, Cultured</subject><subject>Gene Knock-In Techniques</subject><subject>Hypothermia - chemically induced</subject><subject>Hypothermia - mortality</subject><subject>Inflammation - genetics</subject><subject>Inflammation - immunology</subject><subject>Macrophages - immunology</subject><subject>MAP Kinase Signaling System - immunology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Necrosis - chemically induced</subject><subject>Necrosis - immunology</subject><subject>NF-kappa B - immunology</subject><subject>Poly I-C - pharmacology</subject><subject>Receptor-Interacting Protein Serine-Threonine Kinases - genetics</subject><subject>Receptor-Interacting Protein Serine-Threonine Kinases - immunology</subject><subject>Receptors, Tumor Necrosis Factor, Type I - immunology</subject><subject>Tumor Necrosis Factor-alpha - immunology</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Vaccinia - immunology</subject><subject>Vaccinia virus</subject><subject>Vaccinia virus - growth &amp; development</subject><subject>Vaccinia virus - immunology</subject><subject>Virus Replication - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9kM1LAzEQxYMotlbvniRHL6uTbJJuvEnxo7SoSO_LbnZSUvajbrIF_3tT2nqZGYb3fjweIbcMHgQI_bhxTTO0Xf3ABIDUcEbGTEpIlAJ1TsYAnCdsqqYjcuX9BgAUcHFJRlwCkxlnY2JnQwiuXVOs1vhEv-dfC0YXri080jhNcDukjTNIix7pzhVlHc-2otu-C2gCVtT2XUNXH6-Ja6vBxEeLpu-2ofPOR0Y07bprcmGL2uPNcU_I6vVlNXtPlp9v89nzMjFCQEi04mUlJNNCcQ4sFahTxZTRGKPLDBnLUmlEqdFgyVKtbMltClNrVGEVTyfk_oCN6X4G9CFvnDdY10WL3eBzlkEWyZneS-EgjVm979Hm2941Rf-bM8j35eancvNjudFyd6QPZYPVv-HUZvoH4Z52QQ</recordid><startdate>20140815</startdate><enddate>20140815</enddate><creator>Polykratis, Apostolos</creator><creator>Hermance, Nicole</creator><creator>Zelic, Matija</creator><creator>Roderick, Justine</creator><creator>Kim, Chun</creator><creator>Van, Trieu-My</creator><creator>Lee, Thomas H</creator><creator>Chan, Francis K M</creator><creator>Pasparakis, Manolis</creator><creator>Kelliher, Michelle A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20140815</creationdate><title>Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo</title><author>Polykratis, Apostolos ; Hermance, Nicole ; Zelic, Matija ; Roderick, Justine ; Kim, Chun ; Van, Trieu-My ; Lee, Thomas H ; Chan, Francis K M ; Pasparakis, Manolis ; Kelliher, Michelle A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-962bd451946220134e93616c9e00658e11835c4b9eceb1396fb2f307fc6af623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adaptor Proteins, Vesicular Transport - immunology</topic><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - immunology</topic><topic>Cells, Cultured</topic><topic>Gene Knock-In Techniques</topic><topic>Hypothermia - chemically induced</topic><topic>Hypothermia - mortality</topic><topic>Inflammation - genetics</topic><topic>Inflammation - immunology</topic><topic>Macrophages - immunology</topic><topic>MAP Kinase Signaling System - immunology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Necrosis - chemically induced</topic><topic>Necrosis - immunology</topic><topic>NF-kappa B - immunology</topic><topic>Poly I-C - pharmacology</topic><topic>Receptor-Interacting Protein Serine-Threonine Kinases - genetics</topic><topic>Receptor-Interacting Protein Serine-Threonine Kinases - immunology</topic><topic>Receptors, Tumor Necrosis Factor, Type I - immunology</topic><topic>Tumor Necrosis Factor-alpha - immunology</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Vaccinia - immunology</topic><topic>Vaccinia virus</topic><topic>Vaccinia virus - growth &amp; development</topic><topic>Vaccinia virus - immunology</topic><topic>Virus Replication - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polykratis, Apostolos</creatorcontrib><creatorcontrib>Hermance, Nicole</creatorcontrib><creatorcontrib>Zelic, Matija</creatorcontrib><creatorcontrib>Roderick, Justine</creatorcontrib><creatorcontrib>Kim, Chun</creatorcontrib><creatorcontrib>Van, Trieu-My</creatorcontrib><creatorcontrib>Lee, Thomas H</creatorcontrib><creatorcontrib>Chan, Francis K M</creatorcontrib><creatorcontrib>Pasparakis, Manolis</creatorcontrib><creatorcontrib>Kelliher, Michelle A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polykratis, Apostolos</au><au>Hermance, Nicole</au><au>Zelic, Matija</au><au>Roderick, Justine</au><au>Kim, Chun</au><au>Van, Trieu-My</au><au>Lee, Thomas H</au><au>Chan, Francis K M</au><au>Pasparakis, Manolis</au><au>Kelliher, Michelle A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2014-08-15</date><risdate>2014</risdate><volume>193</volume><issue>4</issue><spage>1539</spage><epage>1543</epage><pages>1539-1543</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>The serine/threonine kinase RIPK1 is recruited to TNFR1 to mediate proinflammatory signaling and to regulate TNF-induced cell death. A RIPK1 deficiency results in perinatal lethality, impaired NFκB and MAPK signaling, and sensitivity to TNF-induced apoptosis. Chemical inhibitor and in vitro-reconstitution studies suggested that RIPK1 displays distinct kinase activity-dependent and -independent functions. To determine the contribution of RIPK1 kinase to inflammation in vivo, we generated knock-in mice endogenously expressing catalytically inactive RIPK1 D138N. Unlike Ripk1(-/-) mice, which die shortly after birth, Ripk1(D138N/D138N) mice are viable. Cells expressing RIPK1 D138N are resistant to TNF- and polyinosinic-polycytidylic acid-induced necroptosis in vitro, and Ripk1(D138N/D138N) mice are protected from TNF-induced shock in vivo. Moreover, Ripk1(D138N/D138N) mice fail to control vaccinia virus replication in vivo. This study provides genetic evidence that the kinase activity of RIPK1 is not required for survival but is essential for TNF-, TRIF-, and viral-initiated necroptosis.</abstract><cop>United States</cop><pmid>25015821</pmid><doi>10.4049/jimmunol.1400590</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 2014-08, Vol.193 (4), p.1539-1543
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_1808622892
source EZB Electronic Journals Library
subjects Adaptor Proteins, Vesicular Transport - immunology
Animals
Apoptosis - drug effects
Apoptosis - immunology
Cells, Cultured
Gene Knock-In Techniques
Hypothermia - chemically induced
Hypothermia - mortality
Inflammation - genetics
Inflammation - immunology
Macrophages - immunology
MAP Kinase Signaling System - immunology
Mice
Mice, Inbred C57BL
Necrosis - chemically induced
Necrosis - immunology
NF-kappa B - immunology
Poly I-C - pharmacology
Receptor-Interacting Protein Serine-Threonine Kinases - genetics
Receptor-Interacting Protein Serine-Threonine Kinases - immunology
Receptors, Tumor Necrosis Factor, Type I - immunology
Tumor Necrosis Factor-alpha - immunology
Tumor Necrosis Factor-alpha - pharmacology
Vaccinia - immunology
Vaccinia virus
Vaccinia virus - growth & development
Vaccinia virus - immunology
Virus Replication - immunology
title Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutting%20edge:%20RIPK1%20Kinase%20inactive%20mice%20are%20viable%20and%20protected%20from%20TNF-induced%20necroptosis%20in%20vivo&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Polykratis,%20Apostolos&rft.date=2014-08-15&rft.volume=193&rft.issue=4&rft.spage=1539&rft.epage=1543&rft.pages=1539-1543&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.1400590&rft_dat=%3Cproquest_cross%3E1808622892%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-962bd451946220134e93616c9e00658e11835c4b9eceb1396fb2f307fc6af623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1808622892&rft_id=info:pmid/25015821&rfr_iscdi=true